agilon health Q1 EPS Forecast Increased by William Blair

agilon health, inc. (NYSE:AGL) – Stock analysts at William Blair increased their Q1 2026 earnings estimates for agilon health in a research note issued to investors on Tuesday, May 6th. William Blair analyst R. Daniels now anticipates that the company will post earnings of $0.09 per share for the quarter, up from their prior estimate of $0.05. The consensus estimate for agilon health’s current full-year earnings is ($0.59) per share.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the previous year, the company earned ($0.02) EPS. The company’s quarterly revenue was down 4.5% on a year-over-year basis.

Other equities research analysts have also issued reports about the stock. Royal Bank of Canada boosted their price objective on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Stifel Nicolaus increased their price target on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. TD Cowen upped their target price on agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a research note on Tuesday, April 15th. Finally, Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $4.89.

agilon health Stock Down 10.9 %

AGL opened at $2.87 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market cap of $1.19 billion, a price-to-earnings ratio of -3.05 and a beta of 0.38. agilon health has a one year low of $1.50 and a one year high of $7.73. The business’s fifty day moving average is $4.27 and its two-hundred day moving average is $3.19.

Hedge Funds Weigh In On agilon health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Barclays PLC grew its stake in shares of agilon health by 21.2% during the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after buying an additional 214,830 shares during the period. Virtu Financial LLC acquired a new position in agilon health in the third quarter valued at $120,000. JPMorgan Chase & Co. grew its position in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the period. Pines Wealth Management LLC acquired a new stake in agilon health during the fourth quarter worth about $51,000. Finally, Oak Thistle LLC purchased a new position in shares of agilon health in the 4th quarter worth about $25,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.